Lindbrook Capital LLC Sells 264 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Lindbrook Capital LLC lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.0% in the fourth quarter, HoldingsChannel.com reports. The fund owned 12,849 shares of the healthcare conglomerate’s stock after selling 264 shares during the quarter. UnitedHealth Group comprises 0.6% of Lindbrook Capital LLC’s portfolio, making the stock its 27th biggest position. Lindbrook Capital LLC’s holdings in UnitedHealth Group were worth $6,500,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors also recently modified their holdings of the company. M&T Bank Corp raised its stake in shares of UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares during the last quarter. Sugarloaf Wealth Management LLC raised its position in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. raised its position in UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock worth $26,060,000 after purchasing an additional 41,308 shares during the last quarter. Parsifal Capital Management LP bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $21,165,000. Finally, Signal Advisors Wealth LLC raised its position in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after purchasing an additional 1,051 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $476.22 on Thursday. The firm has a market cap of $438.25 billion, a PE ratio of 30.72, a PEG ratio of 1.37 and a beta of 0.61. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a fifty day moving average price of $514.58 and a 200 day moving average price of $554.81.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same period in the previous year, the firm posted $5.83 EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.76%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Oppenheimer lifted their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Barclays lowered their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $629.32.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were bought at an average cost of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.